Protective effect of arctigenin against MPP+ and MPTP-induced neurotoxicity

Planta Medica

Volumn 80, Issue 1, 2014, Pages 48-55

  Li, Dongwei ^a   Liu, Qingping ^b   Jia, Dong ^a   Dou, Deqiang ^a   Wang, Xiaofei ^a   Kang, Tingguo ^a  

^a LIAONING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b DALIAN UNIVERSITY   (China)

Author keywords

anti apoptosis; arctigenin; neuroprotective effect; oxidative stress; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 AMINOBUTYRIC ACID; ARCTIGENIN; CASPASE 3; DOPAMINE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; IN VIVO STUDY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEUROBLASTOMA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; UPREGULATION;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BEHAVIOR, ANIMAL; BRAIN; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; FURANS; GAMMA-AMINOBUTYRIC ACID; HUMANS; LIGNANS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, INBRED C57BL; MPTP POISONING; NEUROBLASTOMA; NEUROPROTECTIVE AGENTS; NEUROTOXICITY SYNDROMES; PARKINSON DISEASE;

EID: 84892387002     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0033-1360171     Document Type: Article

References (50)

1. Aarsland D., Londos E., Ballard C. Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entity. Int Psychogeriatr: 2009; 2 216 219
2. Mattson M. P. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol: 1990; 1 120 129
3. Jomova K., Vondrakova D., Lawson M., Valko M. M. Oxidative stress and neurodegenerative disorders. Mol Cell Biochem: 2010; 345 91 104
4. Swarup V., Ghosh J., Mishra M. K., Basu A. Novel strategy for treatment of Japanese encephalitis using arctigenin, a plant lignan. J Antimicrob Chemother: 2008; 3 679 688 (Pubitemid 351321147)
5. Zhao H., Wang J., Yang S. S. Chemical composition and pharmacological activity of medicinal plants Arctium lappa L. Summary. J Liaoning Coll TCM: 2005; 7 128 129
6. Krantz J. C., Cair C. J. A physicochemical study of the carbohydrate occurring in the root of Arctium lappa. J Pharm: 1897; 72 416 424
7. Nose M., Fujimoto T., Nishibe S., Ogihara Y. Structural transformation of lignan compounds in rat gastrointestinal tract; II. Serum concentration of lignans and their metabolites. Planta Med: 1993; 2 131 134 (Pubitemid 23116483)
8. Chinese Pharmacopoeia Commission The Pharmacopoeia of the People's Republic of China, Vol. 1. Beijing China Medical Science Press: 2010; 66 67
9. Young P. J., Kim S. R., Choi Y. H., Kim J., Kim S. G., Markelonis G. J., Oh T. H., Kim Y. C. Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor. J Neurosci Res: 2002; 68 233 240 (Pubitemid 34275016)
10. Jang Y. P., Kim S. R., Choi Y. H., Kim J., Kim S. G., Markelonis G. J., Oh T. H., Kim Y. C. Arctigenin protects cultured cortical neurons from glutamate-induced neurodegeneration by binding to kainate receptor. J Neurosci Res: 2002; 2 233 240 (Pubitemid 34275016)
11. Lee J. Y., Kim C. J. Arctigenin, a phenylpropanoid dibenzylbutyrolactone lignan, inhibits type I-IV allergic inflammation and pro-inflammatory enzymes. Arch Pharm Res: 2010; 33 947 957
12. Chung Y. C., Ko H. W., Bok E., Park E. S., Huh S. H., Nam J. H., Jin B. K. The role of neuroinflammation on the pathogenesis of Parkinson's disease. BMB Rep: 2010; 43 225 232
13. Wilms H., Zecca L., Rosenstiel P., Sievers J., Deuschl G., Lucius R. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des: 2007; 18 1925 1928 (Pubitemid 47017994)
14. Wang W., Pan Q., Han X. Y., Wang J., Tan R. Q., He F., Dou D. Q., Kang T. G. Simultaneous determination of arctiin and its metabolites in rat urine and feces by HPLC. Fitoterapia: 2013; 86 6 12
15. Smiley S. T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T. W., Steele G. D. jr., Chen L. B. Intracellular-heterogeneity in mitochondrial membrane potential revealed by J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A: 1991; 9 3671 3675 (Pubitemid 21916685)
16. Morizane A., Li J. Y., Brundin P. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease. Cell Tissue Res: 2008; 331 323 336 (Pubitemid 50004907)
17. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol: 2003; 53 26 38
18. Lev N., Melamed E., Offen D. Apoptosis and Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry: 2003; 27 245 250 (Pubitemid 36351491)
19. Ishihara K., Yamagishi N., Saito Y., Takasaki M., Konoshima T., Htayama T. Arctigenin from Fructus Arctii is a novel suppressor of heat shock response in mammalian cells. Cell Stress Chaperones: 2006; 11 154 161 (Pubitemid 43946313)
20. Kang H. S., Lee J. Y., Kim C. J. Anti-inflammatory activity of arctigenin from Forsythiae Fructus. J Ethnopharmacol: 2008; 116 305 312
21. Jang Y. P., Kim S. R., Kim Y. C. Neuroprotective dibenzylbutyrolactone lignans of Torreya nucifera. Planta Med: 2001; 67 470 472
22. Ma C. J., Sung S. H., Kim Y. C. New neuroprotective dibenzylbutane lignans isolated from Machilus thunbergii. Nat Prod Res: 2010; 6 562 568
23. Solano R. M., Menéndez J., Casarejos M. J., Rodríguez- Navarro J. A., García de Yébenes J., Mena M. A. Midbrain neuronal cultures from parkin mutant mice are resistant to nitric oxide-induced toxicity. Neuropharmacology: 2006; 51 327 340 (Pubitemid 44061892)
24. Boulet S., Mounayar S., Poupard A., Bertrand A., Jan C., Pessiglione M., Hirsch E. C., Feuerstein C., Francois C., Feger J., Savasta M., Tremblay L. Behavioral recovery in MPTP-treated monkeys: neurochemical mechanisms studied by intrastriatal microdialysis. J Neurosci: 2008; 38 9575 9584
25. Winkler C., Bentlage C., Nikkhah G., Samii M., Björklund A. Intranigral transplants of GABA-rich striatal tissue induce behavioral recovery in the rat Parkinson model and promote the effects obtained by intrastriatal dopaminergic transplants. Exp Neurol: 1999; 2 165 186 (Pubitemid 29124711)
26. Tatton N. A., Kish S. J. In situ detection of apoptotic nuclei in the substantia nigra pars compacta of 1-methyl-4-phenyl-1,2,3,6- tetrahydrophenylpyridine - treated mice using terminal deoxynucleotidyl transferase labeling and acridine orange. Neuroscience: 1997; 77 1037 1048
27. + (1-methyl-4-phenylpyridine) is a neurotoxin to dopamine-, norepinephrine- and serotonin-containing neurons. Eur J Pharmacol: 1987; 136 31 37 (Pubitemid 17109588)
28. Greenamyre J. T., Shere T. B., Betarbet R., Panov A. V. Complex I and Parkinson's disease. IUBMB Life: 2001; 52 135 141 (Pubitemid 33731566)
29. Xie H. R., Hu L. S., Li G. Y. SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson's disease. Chin Med J: 2010; 123 1086 1092
30. +-induced apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res: 1999; 55 620 628 (Pubitemid 29117620)
31. Bruno D., Marini A. M., Youle R. J. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem Biophys Res Commun: 1991; 181 1442 1448
32. Cory S., Adams J. M. The Bcl-2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer: 2002; 2 647 656 (Pubitemid 37328916)
33. +)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci: 2003; 18 1387 1401 (Pubitemid 37215094)
34. Salvesen G. S., Dixit V. M. Caspases: intracellular signaling by proteolysis. Cell: 1997; 91 443 446 (Pubitemid 27508233)
35. +)-induced apoptosis and alternations of related signal transduction in SH-SY5Y cells. Neuropharmacology: 2007; 52 423 429 (Pubitemid 46123358)
36. Lindsay J., Esposti M. D., Gilmore A. P. Bcl-2 proteins and mitochondria-specificity in membrane targeting for death. Biochem Biophys Acta: 2011; 1813 523 529
37. +-induced cytotoxicity by anti-oxidation and inhibition of MKK4 and JNK activation in MES23.5 cells. Neuropharmacology: 2011; 61 329 335
38. Le D. A., Wu Y., Huang Z., Matsushita K., Plesnila N., Augustinack J. C., Hyman B. T., Yuan J., Kuida K., Flavell R. A., Moskowitz M. A. Caspase activation and neuroprotection in caspase-3-deficient mice after in vivo cerebral ischemia and in vitro oxygen glucose deprivation. Proc Natl Acad Sci USA: 2002; 99 15188 15193 (Pubitemid 35334631)
39. Chen Y., McMillan-Ward E., Kong J., Israels S. J., Gibson S. B. Mitochondrial electron-transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci: 2007; 120 4155 4166
40. + induced cytotoxicity via inhibition of mitochondrial dysfunction and ROS production. J Neurol Sci: 2007; 253 53 60 (Pubitemid 46185454)
41. +) -induced cytotoxicity via the downregulation of ROS generation and JNK signalling. Neurosci Lett: 2007; 413 132 136
42. Prehn J. H., Bindokas V. P., Jordan J., Galindo M. F., Ghadge G. D., Roos R. P., Boise L. H., Thompson C. B., Krajewski S., Reed J. C., Miller R. J. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol: 1996; 49 319 328 (Pubitemid 26066118)
43. Hou Q., He F., Dou D. Q., Kang T. G., Li H. F. New preparation method of arctigenin from Fructus Arctii. Chin J New Drugs: 2011; 20 871 873
44. Matsuura K., Kabuto H., Makino H., Ogawa N. Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods: 1997; 73 45 48 (Pubitemid 27166123)
45. Donnan G. A., Willis G. L., Kaczmarczyk S. J., Rowe P. Motor function in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. J Neurol Sci: 1987; 77 185 191 (Pubitemid 17231293)
46. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods: 1983; 65 55 63 (Pubitemid 14203433)
47. Schneider L., Giordano S., Zelickson B. R., Johnson M. S., Benavides G. A., Ouyang X., Fineberg N., Darley-Usmar V. M., Zhang J. Differentiation of SH-SY5Y cells to a neuronal phenotype changes cellular bioenergetics and the response to oxidative stress. Free Radic Biol Med: 2011; 51 2007 2017
48. +-induced neurotoxicity in SH-SY5Y cells. Free Radic Biol Med: 2010; 49 839 846
49. LeBel C. P., Ali S. F., McKee M., Bondy S. C. Organometal-induced increases in oxygen reactive species: the potential of 2′,7′- dichlorofluorescin diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol: 1990; 104 17 24 (Pubitemid 20186895)
50. Im J. Y., Han P. L. Nordihydroguaiaretic acid induces astroglial death via glutathione depletion. J Neurosci Res: 2007; 85 3127 3134